TALPHERA, INC. — Director's Dealing 2017

Oct 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2017-10-02

Reporting Person: Hamel Lawrence G (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-02	Common Stock	S	10161	$5.29	Disposed	41964	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	16379	Direct

Footnotes

F1: Shares sold pursuant to a 10b5-1 plan.

F2: The Shares were sold at prices ranging from $5.10 to $5.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: The Shares are held in the Hamel Revocable Living Trust.